Propanc Biopharma

302/6 Butler Street

Show articles for this employer

About Propanc Biopharma

Propanc Biopharma is a clinical stage biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ pancreatic proenzymes, which are inactive precursors of enzymes. In the near term, we intend to target patients with limited remaining therapeutic options for the treatment of solid tumors. In future, we intend to develop our lead product to treat (i) early stage cancer and (ii) pre-cancerous diseases and (iii) as a preventative measure for patients at risk of developing cancer based on genetic screening.


November 23, 2010


Founders: James Nathanielsz and Julian Kenyon

Founder and CEO: James Nathanielsz

Founder and CSO: Julian Kenyon

CMO: Klaus Kutz


Please click here for clinical trial information.

Currently, there are no jobs for this employer on BioSpace.

Browse jobs with BioSpace Featured Employers here.